These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3368337)

  • 21. 24-Hour/4-hour ratio of technetium-99m methylene diphosphonate uptake in patients with bone metastases and degenerative bone changes.
    Israel O; Front D; Frenkel A; Kleinhaus U
    J Nucl Med; 1985 Mar; 26(3):237-40. PubMed ID: 3156220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A phosphine-substituted diphosphonic acid (HMPD) for improved scintigraphic detection of bone lesions].
    Steinsträsser A; Schwarz A; Alexander C; Berberich R; Zimmer M
    Nuklearmedizin; 1992 Oct; 31(5):164-71. PubMed ID: 1465353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)?
    Frühling J; Verbist A; Balikdjian D
    Nucl Med Commun; 1986 Jun; 7(6):415-25. PubMed ID: 3748485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical comparison of MDP and DMAD.
    Rosenthall L; Stern J; Arzoumanian A
    Clin Nucl Med; 1982 Sep; 7(9):403-6. PubMed ID: 6214358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
    Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB
    J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
    Coleman RE; Meier CA; Rubens RD; Fogelman I
    Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
    Domstad PA; Coupal JJ; Kim EE; Blake JS; DeLand FH
    Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biokinetics of osteotropic radiopharmaceuticals in metabolic osteopathy--comparison of 47Ca and 99mTc-methylene-diphosphonate (MDP)].
    Knop J; Montz R
    Nuklearmedizin; 1983 Oct; 22(5):226-31. PubMed ID: 6228781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of a brain metastasis from osteosarcoma with 99mTc-methylene diphosphonate bone scanning.
    Ozarda AT; Legaspi JR; Haynie TP
    Eur J Nucl Med; 1983; 8(12):552-4. PubMed ID: 6230234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of the phosphate balance on the activity distribution of 99mTc-hydroxy-methylene diphosphonate. Experimental studies in the mouse.
    Cronhjort M; Sääf M; Sjöberg HE; Schnell PO; Jacobsson H
    Acta Radiol; 1998 Jul; 39(4):427-33. PubMed ID: 9685832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.
    Hoefnagel CA; Bruning PF; Cohen P; Marcuse HR; van der Schoot JB
    Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of 113mIn-DTPMP and 99mTc-MDP for bone scanning].
    Yang JS
    Zhonghua Fang She Xue Za Zhi; 1984 Feb; 18(1):58-62. PubMed ID: 6236062
    [No Abstract]   [Full Text] [Related]  

  • 33. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
    Littlefield JL; Rudd TG
    J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gallium-67/technetium-99m methylene diphosphonate ratio imaging: early rabbit osteomyelitis and fracture.
    Hartshorne MF; Graham G; Lancaster J; Berger D
    J Nucl Med; 1985 Mar; 26(3):272-7. PubMed ID: 3156223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
    Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
    J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Labeling efficiency and stomach concentration in methylene diphosphonate bone imaging.
    Dhawan V; Yeh SD
    J Nucl Med; 1979 Jul; 20(7):791-3. PubMed ID: 541718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophoretic analysis of different technetium-99m (SnCl2) methylene diphosphonate complexes.
    Najafi A; Hutchison N
    J Nucl Med; 1985 May; 26(5):524-30. PubMed ID: 3157787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrolytically labeled [99mTc]MDP: chromatographic pattern, stability and biodistribution in rats.
    Savelkoul TJ; Oldenburg SJ; Van Oort WJ; Duursma SA
    Int J Appl Radiat Isot; 1984 Aug; 35(8):709-13. PubMed ID: 6237064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deconvolution analysis of 99mTc-methylene diphosphonate kinetics in metabolic bone disease.
    Knop J; Kröger E; Stritzke P; Schneider C; Kruse HP
    Eur J Nucl Med; 1981 Feb; 6(2):63-7. PubMed ID: 6451429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.